Efficacy and Safety of Anlotinib in the Treatment of Small Cell Lung Cancer: A Real-World Observation Study

AIMS: This study aimed to observe the efficacy and safety of anlotinib in the treatment of small cell lung cancer (SCLC) in the real world, as first-line maintenance therapy, second-line, and above. METHODS: Clinical data of 109 patients with SCLC treated with anlotinib and hospitalized at The First...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Jing, Cheng, Feng, Xiao, Guodong, Wang, Xiaofeng, Fan, Huijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251318/
https://www.ncbi.nlm.nih.gov/pubmed/35795060
http://dx.doi.org/10.3389/fonc.2022.917089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251318/
https://www.ncbi.nlm.nih.gov/pubmed/35795060
http://dx.doi.org/10.3389/fonc.2022.917089

Ejemplares similares